SANJIVIN Sanjivani Paranteral Ltd Investor Conferences Announcement 2025 - Q3 Investor Presentation Sanjivani Parenteral Ltd. presented their performance report for Q3 FY25, showing a 25% increase in revenue year-over-year to Rs. 519.2 million and a 20.4% increase in PAT to Rs. 59.1 million..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Sanjivani Paranteral Ltd